Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ferrer Freeman & Company is a private equity and growth capital investment firm focused exclusively on the healthcare sector. Since its founding in 1995, it has invested over $900 million in more than 36 portfolio companies across healthcare services, medical products, pharmaceuticals, therapeutics, and related infrastructure. The firm's strategy centers on partnering with established lower/middle-market companies with significant growth potential and entrepreneurial management teams to accelerate value creation through operational improvements and strategic guidance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ferrer Freeman & Company.